
Walter J. Divito
Examiner (ID: 6693, Phone: (571)272-2556 , Office: P/2465 )
| Most Active Art Unit | 2465 |
| Art Unit(s) | 2465, 2419 |
| Total Applications | 692 |
| Issued Applications | 527 |
| Pending Applications | 98 |
| Abandoned Applications | 91 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17200406
[patent_doc_number] => 20210340501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => Methods to Control Viral Infection in Mammalian Cells
[patent_app_type] => utility
[patent_app_number] => 17/270501
[patent_app_country] => US
[patent_app_date] => 2019-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/270501 | Methods to Control Viral Infection in Mammalian Cells | Aug 26, 2019 | Pending |
Array
(
[id] => 17170750
[patent_doc_number] => 20210324420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHOD FOR PRODUCING GENOME-EDITED CELL
[patent_app_type] => utility
[patent_app_number] => 17/294165
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/294165 | Method for producing genome-edited cell | Aug 6, 2019 | Issued |
Array
(
[id] => 17156384
[patent_doc_number] => 20210317435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => DOUBLE KNOCK-OUT CHO CELL LINE METHOD OF ITS GENERATION AND PRODUCING THERAPEUTIC PROTEINS THEREFROM
[patent_app_type] => utility
[patent_app_number] => 17/259950
[patent_app_country] => US
[patent_app_date] => 2019-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259950
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259950 | Double knock-out CHO cell line method of its generation and producing therapeutic proteins therefrom | Jul 12, 2019 | Issued |
Array
(
[id] => 17097218
[patent_doc_number] => 20210285009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => RETROTRANSPOSON-BASED DELIVERY VEHICLE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/257796
[patent_app_country] => US
[patent_app_date] => 2019-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257796
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257796 | RETROTRANSPOSON-BASED DELIVERY VEHICLE AND METHODS OF USE THEREOF | Jul 10, 2019 | Pending |
Array
(
[id] => 20453324
[patent_doc_number] => 12516376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Optimizing BAG3 gene therapy
[patent_app_type] => utility
[patent_app_number] => 16/973353
[patent_app_country] => US
[patent_app_date] => 2019-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 20735
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973353
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973353 | Optimizing BAG3 gene therapy | Jun 6, 2019 | Issued |
Array
(
[id] => 19166019
[patent_doc_number] => 11981909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Circular RNA for translation in eukaryotic cells
[patent_app_type] => utility
[patent_app_number] => 16/432177
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 131
[patent_no_of_words] => 26561
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16432177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/432177 | Circular RNA for translation in eukaryotic cells | Jun 4, 2019 | Issued |
Array
(
[id] => 16963250
[patent_doc_number] => 20210214749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => DIRECTED EVOLUTION
[patent_app_type] => utility
[patent_app_number] => 17/055842
[patent_app_country] => US
[patent_app_date] => 2019-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055842 | DIRECTED EVOLUTION | May 15, 2019 | Abandoned |
Array
(
[id] => 16712213
[patent_doc_number] => 20210079360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => VIRAL VECTOR PRODUCTION SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/980825
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980825
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980825 | VIRAL VECTOR PRODUCTION SYSTEM | Mar 14, 2019 | Abandoned |
Array
(
[id] => 18537791
[patent_doc_number] => 20230242891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => NOVEL CRISPR DNA AND RNA TARGETING ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/980246
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980246
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980246 | CRISPR DNA and RNA targeting enzymes and systems | Mar 13, 2019 | Issued |
Array
(
[id] => 16660403
[patent_doc_number] => 20210057040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => Gene Panel for Personalized Medicine, Method for Forming Same, and Personalized Treatment Method Using Same
[patent_app_type] => utility
[patent_app_number] => 16/966567
[patent_app_country] => US
[patent_app_date] => 2019-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966567
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966567 | Gene Panel for Personalized Medicine, Method for Forming Same, and Personalized Treatment Method Using Same | Jan 29, 2019 | Abandoned |
Array
(
[id] => 19738516
[patent_doc_number] => 12215335
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Non-integrating DNA vectors for the genetic modification of cells
[patent_app_type] => utility
[patent_app_number] => 16/648885
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11461
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648885
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648885 | Non-integrating DNA vectors for the genetic modification of cells | Sep 16, 2018 | Issued |
Array
(
[id] => 11716103
[patent_doc_number] => 20170184601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'CANCER BIOMARKERS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/284349
[patent_app_country] => US
[patent_app_date] => 2016-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 74542
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15284349
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/284349 | CANCER BIOMARKERS AND METHODS OF USE THEREOF | Oct 2, 2016 | Pending |
Array
(
[id] => 10730931
[patent_doc_number] => 20160077081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'METHOD FOR A CELL-BASED DRUG SCREENING ASSAY AND THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/786637
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 5069
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786637
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/786637 | METHOD FOR A CELL-BASED DRUG SCREENING ASSAY AND THE USE THEREOF | Apr 21, 2014 | Abandoned |